Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

CAPS Rating: 2 out of 5

The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.

Recs

0
Player Avatar jwray01 (99.64) Submitted: 8/15/2012 2:25:43 AM : Underperform Start Price: $4.57 ROSG Score: +5.50

stock spam

Featured Broker Partners


Advertisement